Adapting to Telemedicine in Diabetes

Abstract

THIS year’s European Association for the Study of Diabetes (EASD) Annual Meeting 2022 was a hybrid congress, which focused on inclusion and interaction within the global diabetes community whether participants attended in person in Stockholm, Sweden, or virtually. In front of a live audience, Richard Holt, Professor in Diabetes and Endocrinology at University of Southampton, UK, delivered the presentation, ‘“I just called to say I love you...” Diabetes tools for telemedicine: What we learned from COVID-19 and beyond?’ Holt spoke on how telemedicine has become increasingly popular in diabetes consultations, and how there has been a major rise in its use as a result of the pandemic. Holt reviewed the evidence on telemedicine for diabetes care, before exploring the practical issues experienced by patients and healthcare professionals during the pandemic, taking these as lessons to better inform how we can use telemedicine going forward. The COVID-19 pandemic has led to a rapid expansion of the use of telemedicine, and many have had to adapt to the use of this in diabetes care.